Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

This is good for Obamacare: DC Circuit court will review Halbig

A major ruling against Obamacare is getting a second look.

The Appeals Court for the District of Columbia announced Thursday that it would re-hear Halbig v. Burwell en banc, meaning the entire panel of 11 judges will weigh in on the case. There will also be two senior judges who hear the case, but do not vote.

The D.C. Circuit Court previously ruled against the Affordable Care Act in its initial Halbig decision. It found that Obamacare subsidies were illegal in the 36 states where the federal government was running the health insurance exchange.

The en banc review has potential to be a big win for Obamacare because it opens up the possibility of the DC Circuit Court reversing its decision. The Fourth Circuit already ruled for Obamacare in a separate, Halbig-like case. If the en banc DC Circuit ruling also rules for the government, that would bring the two appellate courts into agreement on the subsidies’ legality.

And that could lessen the chances of this particular issue ever reaching the Supreme Court, which typically likes to opine on issues where there is a split in circuit opinions.

We don’t fully know how the en banc review will go for Obamacare, but the political make up of the panel does suggest a potentially friendlier venue for the law than the initial hearing.

You can read more about the original Halbig decision here (or a shorter, three sentence summary here).

More in Health Care

Health
Hantavirus will test if the world learned anything from CovidHantavirus will test if the world learned anything from Covid
Health

The hantavirus outbreak is still small. But it’s a huge test for a battered public health sector.

By Dylan Scott
Health
How worried should I be about hantavirus?How worried should I be about hantavirus?
Health

5 questions about the hantavirus cruise ship outbreak, answered.

By Dylan Scott
Good Medicine
Do health influencers actually know what they’re talking about?Do health influencers actually know what they’re talking about?
Good Medicine

Most health influencers don’t have real credentials — but they are more influential than ever.

By Dylan Scott
Health
A major new study found AI outperformed doctors in ER diagnosis — but there’s a catchA major new study found AI outperformed doctors in ER diagnosis — but there’s a catch
Health

An Open AI model posted impressive results in emergency care. But we still need human doctors.

By Dylan Scott
Health
Please don’t inject yourself with bootleg peptidesPlease don’t inject yourself with bootleg peptides
Health

Why Americans have gone wild self-experimenting with the hottest thing in wellness: Peptides.

By Dylan Scott
Health
RFK Jr. is in his influencer eraRFK Jr. is in his influencer era
Health

The real reason Trump’s health secretary is launching a podcast.

By Dylan Scott